An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients
Tacrolimus (TAC), a calcineurin inhibitor, and everolimus (EVL), an mTOR inhibitor, have been used as immunosuppressive (ISS) drugs in post-kidney transplantation therapy. The objective of this study was to compare the efficacy of EVL vs TAC in the ISS maintenance triple therapy. Ninety-seven kidney...
Main Authors: | B.P.S. Assis, M.F. Lasmar, R.A. Fabreti-Oliveira, S.A. Araujo, J. Oliveira, D.C. Wanderley, E. Nascimento |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/pdf/bjmbr/v54n4/1414-431X-bjmbr-54-4-e9369.pdf |
Similar Items
-
Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus
by: Emily A. Bosselmann, et al.
Published: (2023-04-01) -
Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01) -
The Synergistic Effect of Tacrolimus (FK506) or Everolimus and Azoles Against Scedosporium and Lomentospora Species In Vivo and In Vitro
by: Zikuo Wang, et al.
Published: (2022-04-01) -
Cross-sectional analysis of immunosuppressive regimens focused on everolimus after liver transplantation in a Korean high-volume transplantation center
by: Sang-Hyun Kang, et al.
Published: (2019-12-01) -
Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
by: Sebastian C. B. Bremer, et al.
Published: (2018-11-01)